13-48345222-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000321.3(RB1):​c.500+23T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.974 in 1,606,016 control chromosomes in the GnomAD database, including 762,473 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.93 ( 66838 hom., cov: 31)
Exomes 𝑓: 0.98 ( 695635 hom. )

Consequence

RB1
NM_000321.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.319

Publications

16 publications found
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
RB1 Gene-Disease associations (from GenCC):
  • hereditary retinoblastoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • retinoblastoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • melanoma
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 13-48345222-T-G is Benign according to our data. Variant chr13-48345222-T-G is described in ClinVar as Benign. ClinVar VariationId is 255825.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RB1NM_000321.3 linkc.500+23T>G intron_variant Intron 4 of 26 ENST00000267163.6 NP_000312.2 P06400A0A024RDV3
RB1NM_001407165.1 linkc.500+23T>G intron_variant Intron 4 of 26 NP_001394094.1
RB1NM_001407166.1 linkc.500+23T>G intron_variant Intron 4 of 16 NP_001394095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RB1ENST00000267163.6 linkc.500+23T>G intron_variant Intron 4 of 26 1 NM_000321.3 ENSP00000267163.4 P06400

Frequencies

GnomAD3 genomes
AF:
0.934
AC:
142083
AN:
152050
Hom.:
66798
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.821
Gnomad AMI
AF:
0.998
Gnomad AMR
AF:
0.944
Gnomad ASJ
AF:
0.938
Gnomad EAS
AF:
0.997
Gnomad SAS
AF:
0.933
Gnomad FIN
AF:
0.999
Gnomad MID
AF:
0.930
Gnomad NFE
AF:
0.985
Gnomad OTH
AF:
0.945
GnomAD2 exomes
AF:
0.963
AC:
239336
AN:
248654
AF XY:
0.964
show subpopulations
Gnomad AFR exome
AF:
0.818
Gnomad AMR exome
AF:
0.955
Gnomad ASJ exome
AF:
0.932
Gnomad EAS exome
AF:
0.997
Gnomad FIN exome
AF:
0.999
Gnomad NFE exome
AF:
0.985
Gnomad OTH exome
AF:
0.963
GnomAD4 exome
AF:
0.978
AC:
1421424
AN:
1453848
Hom.:
695635
Cov.:
33
AF XY:
0.977
AC XY:
706735
AN XY:
723694
show subpopulations
African (AFR)
AF:
0.814
AC:
27160
AN:
33346
American (AMR)
AF:
0.955
AC:
42649
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.934
AC:
24321
AN:
26048
East Asian (EAS)
AF:
0.998
AC:
39395
AN:
39466
South Asian (SAS)
AF:
0.934
AC:
80376
AN:
86048
European-Finnish (FIN)
AF:
0.998
AC:
50322
AN:
50430
Middle Eastern (MID)
AF:
0.926
AC:
5224
AN:
5640
European-Non Finnish (NFE)
AF:
0.987
AC:
1093908
AN:
1108034
Other (OTH)
AF:
0.965
AC:
58069
AN:
60164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1371
2742
4113
5484
6855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21568
43136
64704
86272
107840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.934
AC:
142184
AN:
152168
Hom.:
66838
Cov.:
31
AF XY:
0.936
AC XY:
69631
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.822
AC:
34084
AN:
41486
American (AMR)
AF:
0.943
AC:
14434
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.938
AC:
3254
AN:
3470
East Asian (EAS)
AF:
0.997
AC:
5162
AN:
5178
South Asian (SAS)
AF:
0.933
AC:
4502
AN:
4824
European-Finnish (FIN)
AF:
0.999
AC:
10589
AN:
10602
Middle Eastern (MID)
AF:
0.939
AC:
276
AN:
294
European-Non Finnish (NFE)
AF:
0.985
AC:
66977
AN:
67990
Other (OTH)
AF:
0.945
AC:
1996
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
420
839
1259
1678
2098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.950
Hom.:
14474
Bravo
AF:
0.927
Asia WGS
AF:
0.954
AC:
3304
AN:
3462

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinoblastoma Benign:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.81
DANN
Benign
0.56
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs198617; hg19: chr13-48919358; COSMIC: COSV99922900; API